Midazolam

For medical students2 min readUpdated 2026-10-10

Midazolam is a non-narcotic hypnotic agent belonging to the benzodiazepine receptor agonists. The drug exerts a pronounced inhibitory effect on the central nervous system, features a short half-life, and is widely used both to facilitate sleep onset and in anesthetic practice.

Drug ClassHypnotics (benzodiazepine derivative)

DurationShort-acting (T1/2 = 1–5 h)

MetabolismCYP3A4 / CYP3A5 isoenzyme substrate

Main RiskRespiratory arrest upon rapid intravenous administration

Mechanism of Action

The action of Midazolam is mediated through the stimulation of benzodiazepine receptors in the central nervous system.

The drug causes allosteric modulation of GABA receptors, which increases the sensitivity of $ ext{GABA}_A$ receptors to the primary inhibitory neurotransmitter, gamma-aminobutyric acid (GABA). As a result, the frequency of chloride channel opening increases. Chloride ions ($ ext{Cl}^-$) enter the cell massively, causing hyperpolarization of the neuronal membrane. The outcome of this cascade is the development of pronounced inhibitory processes in the central nervous system.

Classification and Pharmacokinetics

Among benzodiazepine derivatives, drugs are categorized by the duration of their therapeutic effect. Midazolam (along with triazolam) is classified as a short-acting agent.

Its half-life ($t_{1/2}$) is only 1–5 hours. For comparison: intermediate-acting agents (nitrazepam, phenazepam) act for 12–40 hours, and long-acting agents (diazepam, flurazepam) act from 40 to 250 hours. Due to its short $t_{1/2}$, midazolam does not accumulate in the body and has minimal hangover effects.

Pharmacological Effects and Indications

The main pharmacological effects of the drug are hypnotic and sedative (the latter manifests when used in low doses).

In clinical practice, Midazolam is prescribed in two main settings:

As a hypnotic (per os): primarily prescribed to facilitate sleep onset in insomnia.
In anesthesiology: used for pre-anesthetic medication (premedication) before surgical procedures (administered orally or intramuscularly), and for anesthesia induction (administered intravenously).

Risks and Drug Interactions

Dangers of parenteral administration: When administered intravenously (especially rapidly), there is a high risk of respiratory depression, up to complete respiratory arrest.

Metabolism: Midazolam is a substrate for the most extensive group of hepatic enzymes—the CYP3A4 / CYP3A5 isoenzymes. This requires strict monitoring when co-administered with other drugs:

CYP3A4 inhibitors slow down the breakdown of midazolam, increasing its toxicity. These include azoles (ketoconazole, metronidazole), macrolides (erythromycin, clarithromycin), ciprofloxacin, cardiovascular drugs (verapamil, diltiazem, quinidine), ritonavir, and dietary inhibitors such as the furanocoumarins in grapefruit juice.
CYP3A4 inducers accelerate drug elimination, reducing its efficacy. These include antiepileptic drugs (carbamazepine, phenytoin, barbiturates), rifampicin, macrolides, glucocorticoids, and herbal products (St. John's wort, containing hyperforin).

Formulations and Administration

According to reference formularies, the drug is available in two forms:

Tablets of 0.015 g (15 mg).
Solution in ampoules 0.5% — 3 ml.

Dosage regimens:

Oral (for sleep): 7.5–15 mg at bedtime.
Premedication: 10–15 mg administered intramuscularly 30 minutes before anesthesia.

Mnemonic

MIDAzolam — MIdway to sleep fast (reflects the short duration of 1–5 h and use for rapid sleep onset).

Frequently asked questions

Which drug is used as a specific antidote for midazolam overdose?

Flumazenil is used as a specific antidote for acute midazolam overdose.

Flumazenil is a competitive benzodiazepine receptor antagonist.

The drug is administered via continuous intravenous infusion. It is effective for drug-induced respiratory depression and poisoning by classic benzodiazepines, a group to which midazolam belongs (short-acting benzodiazepine).

What central nervous system side effects, aside from respiratory depression, can midazolam cause?

In addition to respiratory depression, midazolam can cause the following central nervous system side effects:

Anterograde amnesia — loss of memory for events occurring after drug administration (causes short-term amnesia).
CNS depression in newborns — manifests as sedation, feeding difficulties, and weight loss.

In acute benzodiazepine overdose, drowsiness, lethargy, ataxia (impaired coordination), and in severe cases, coma are observed.

What are the absolute contraindications to the use of midazolam?

The provided sources explicitly indicate the following contraindication to the use of midazolam: myasthenia gravis.

Why is midazolam better suited for treating sleep initiation difficulties than diazepam?

Midazolam is a short-acting benzodiazepine (half-life 1–5 h). It rapidly facilitates sleep onset, does not accumulate, and has virtually no morning hangover effect, unlike long-acting diazepam (40–250 h).

What is the main danger of intravenous administration of midazolam?

With intravenous administration, especially when too rapid, there is a high risk of severe respiratory center depression, which can lead to respiratory arrest.

How does grapefruit juice affect the action of midazolam?

Furanocoumarins contained in grapefruit juice are dietary inhibitors of the CYP3A4 isoenzyme. They slow down the hepatic metabolism of midazolam, leading to an unpredictable enhancement of its central nervous system depressant effects.

Go deeper

Allosteric modulation of GABA-A receptors and chloride channels
Classification of non-narcotic hypnotic agents
Cytochrome P450 system: CYP3A4 substrates, inducers, and inhibitors
Premedication and induction of anesthesia in anesthesiology
Z-drugs (zopiclone, zolpidem, zaleplon) and their impact on physiological sleep architecture